A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers

Clinical trial NCT05248841 · COMPLETED

Trial details

NCT number: NCT05248841
Sponsor: Lannett Company, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus

Start date: 2022-03-08
Primary completion: 2022-08-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.